Cover Image

Predictive Efficacy of the Advanced Lung Cancer Inflammation Index in Hepatocellular Carcinoma After Hepatectomy

Xin Qiu,1,2,&ast; Shuang Shen,1,&ast; Donghong Lu,2 Nizhen Jiang,3 Yifei Feng,3 Jindu Li,1 Chenglei Yang,1 Bangde Xiang1,4,5 1Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People's Republic of China; 2Department of Gastroenterology, The First...

Full description

Saved in:

Bibliographic Details
Main Authors:	Qiu X (Author), Shen S (Author), Lu D (Author), Jiang N (Author), Feng Y (Author), Li J (Author), Yang C (Author), Xiang B (Author)
Format:	Book
Published:	Dove Medical Press, 2024-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Systemic Inflammation Response Score for Prognostic Prediction in Hepatocellular Carcinoma Patients After Hepatectomy
by: Zhang D, et al.
Published: (2022)

Prognostic Value of Inflammation-Immunity-Nutrition Score and Inflammatory Burden Index for Hepatocellular Carcinoma Patients After Hepatectomy
by: Song R, et al.
Published: (2022)

Combining Preoperative and Postoperative Inflammatory Indicators Can Better Predict the Recurrence of Hepatocellular Carcinoma After Partial Hepatectomy
by: Wu M, et al.
Published: (2021)

Combining Pre- and Postoperative Lymphocyte–C-Reactive Protein Ratios Can Better Predict Hepatocellular Carcinoma Prognosis After Partial Hepatectomy
by: Ni HH, et al.
Published: (2022)

Association Between Procalcitonin and Post-hepatectomy Liver Failure in Hepatocellular Carcinoma Patients
by: Yi-Ran Li, et al.
Published: (2021)

Safety and Efficacy of Liver Venous Deprivation Following Transarterial Chemoembolization Before Major Hepatectomy for Hepatocellular Carcinoma
by: Sy TV, et al.
Published: (2023)

Left Hepatectomy for Hepatocellular Carcinoma left liver with underlying cirrhosis and portal hypertension
by: Kaushal Yadav
Published: (2018)

Prognosis of Hepatocellular Carcinoma after Liver Transplantation: Comparative Analysis with Partial Hepatectomy
by: Kyuho Lee, et al.
Published: (2017)

C-Reactive Protein-Albumin Ratio (CAR): A More Promising Inflammation-Based Prognostic Marker for Patients Undergoing Curative Hepatectomy for Hepatocellular Carcinoma
by: Mai RY, et al.
Published: (2024)

Effects of Clonorchis sinensis combined with Hepatitis B virus infection on the prognosis of patients with Hepatocellular Carcinoma following Hepatectomy.
by: Yuan-Kuan Li, et al.
Published: (2023)

Combined hepatocellular cholangiocarcinoma in hepatectomy specimens: A clinicopathologic analysis
by: Nayana Patil, et al.
Published: (2023)

Survival benefit of preoperative hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin followed by hepatectomy for hepatocellular carcinoma
by: Zili Hu, et al.
Published: (2023)

Survival benefit of neoadjuvant hepatic arterial infusion chemotherapy followed by hepatectomy for hepatocellular carcinoma with portal vein tumor thrombus
by: Zili Hu, et al.
Published: (2023)

Downregulation of ST6GAL2 Correlates to Liver Inflammation and Predicts Adverse Prognosis in Hepatocellular Carcinoma
by: Liu R, et al.
Published: (2024)

Recent Advances in Hepatocellular Carcinoma Treatment with Radionuclides
by: Ruiqi Liu, et al.
Published: (2022)

Downregulation of ST6GAL1 Promotes Liver Inflammation and Predicts Adverse Prognosis in Hepatocellular Carcinoma
by: Liu R, et al.
Published: (2022)

Massive Hepatocellular Carcinoma with Situs Inversus Totalis Achieved a Complete Response Following Camrelizumab Plus Apatinib and Combined with Two-Stage Hepatectomy: A Case Report
by: Wu Y, et al.
Published: (2023)

Recent advances in systemic therapy for hepatocellular carcinoma
by: Huajun Zhang, et al.
Published: (2022)

Immunotherapies for advanced hepatocellular carcinoma
by: Li-Yang Sun, et al.
Published: (2023)

Advanced Lung Cancer Inflammation Index for Predicting Prognostic Risk for Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
by: Wang X, et al.
Published: (2023)

Efficacy and Safety of Apatinib in Advanced Hepatocellular Carcinoma: A Multicenter Real World Retrospective Study
by: Zhuangzhuang Zheng, et al.
Published: (2022)

Adjuvant therapy with Jianpi Huayu decoction improves overall and recurrence-free survival after hepatectomy for hepatocellular carcinoma: a retrospective propensity score-matching study
by: Rui Luo, et al.
Published: (2023)

Acyl-CoA Binding Domain Containing 4 Polymorphism rs4986172 and Expression Can Serve as Overall Survival Biomarkers for Hepatitis B Virus-Related Hepatocellular Carcinoma Patients After Hepatectomy
by: Huang H, et al.
Published: (2022)

Complications of immunotherapy in advanced hepatocellular carcinoma
by: Young-Gi Song, et al.
Published: (2024)

Complete response to local therapy for advanced hepatocellular carcinoma with lung metastasis: a case report
by: Daeun Kim, et al.
Published: (2022)

Systemic Inflammation Response Index is a Prognostic Risk Factor in Patients with Hepatocellular Carcinoma Undergoing TACE
by: Wang TC, et al.
Published: (2021)

Efficacy and Safety of Sorafenib Versus Supportive Care in Egyptian Advanced Hepatocellular Carcinoma Patients
by: Noha Salah El Baghdady, et al.
Published: (2020)

Real-Life Experience of Regorafenib in Patients With Advanced Hepatocellular Carcinoma
by: Jing-Yu Hou, et al.
Published: (2022)

Advances in immune checkpoint inhibitors for hepatocellular carcinoma
by: Ji Won Han, et al.
Published: (2021)

HEPATOCELLULAR CARCINOMA. RECENT ADVANCES IN DIAGNOSIS AND TREATMENT
by: T. Y. Chernobrovkina, et al.
Published: (2016)

The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer
by: Mengmeng Song, et al.
Published: (2022)

Exploring the implications of modified advanced lung cancer inflammation index on outcomes in patients with advanced non-small cell lung cancer
by: Abhishek Mahajan, et al.
Published: (2023)

An approach to grossing of hepatectomy specimens
by: Archana Rastogi
Published: (2021)

Hepatoid adenocarcinoma of the lung mimicking metastatic hepatocellular carcinoma
by: Yu Miyama, et al.
Published: (2021)

How to predict the development of hepatocellular carcinoma in cirrhotic patients. Despite recent advances, the search continues
by: Camillo Porta, et al.
Published: (2011)

How to predict the development of hepatocellular carcinoma in cirrhotic patients. Despite recent advances, the search continues
by: Camillo Porta, et al.
Published: (2011)

Unleashing the efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma: factors, strategies, and ongoing trials
by: Jiahui Yu, et al.
Published: (2023)

Curcumae Ameliorates Diethylnitrosamine-Induced Hepatocellular Carcinoma via Alteration of Oxidative Stress, Inflammation and Gut Microbiota
by: Zhang Y, et al.
Published: (2021)

Hepatocellular Carcinomas with Granulomatous Inflammation In Tumor Stroma: Clinicopathologic Characteristics
by: Burcu SAKA, et al.
Published: (2022)

Pharmaceutical efficacy of harmalol in inhibiting hepatocellular carcinoma
by: Sarita Sarkar, et al.
Published: (2020)